Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
100,740,741
-
Total 13F shares
-
24,227,264
-
Share change
-
+9,063,718
-
Total reported value
-
$569,258,893
-
Put/Call ratio
-
71%
-
Price per share
-
$23.50
-
Number of holders
-
93
-
Value change
-
+$191,161,902
-
Number of buys
-
80
-
Number of sells
-
18
Institutional Holders of FIBROGEN INC - Common Stock, $0.01 par value (FGEN) as of Q2 2015
As of 30 Jun 2015,
FIBROGEN INC - Common Stock, $0.01 par value (FGEN) was held by
93 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
24,227,264 shares.
The largest 10 holders included
ADAGE CAPITAL PARTNERS GP LLC, VANGUARD GROUP INC, WADDELL & REED FINANCIAL INC, FRANKLIN RESOURCES INC, JPMORGAN CHASE & CO, Visium Asset Management, LP, JANUS CAPITAL MANAGEMENT LLC, EcoR1 Capital, LLC, BlackRock Fund Advisors, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
93
institutional shareholders reporting positions in this security
for the Q2 2015 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.